Sdi Share Discussion Threads

[buywell3] 26/7/2017 10:20

It was a bit longer and positive than their last update granted

Perhaps , as the share price has been 34p recently , if Finncap had been a bit more bullish say at 34p rather than 30p

Still another acquisition now in prospect ... out of 7 being scrutinised

I still think it might be better to parlay Opus into another acquisition that now makes a better fit due to the acquisitions that SDI have made since.

Cross selling opportunities are now being realised from these

Opus is a bit of a dusty standalone




ATIK is leaving it trailing in the dust



... after the 3 years is up ?

[dangersimpson2] 26/7/2017 09:57

I guess technically it was a small miss with 1.71p EPS vs 1.72p consensus, but the outlook statement more than makes up for that IMO:

The Board is confident that SDI is now in an excellent position for profitable growth through increased revenue and the potential for additional acquisitions in 2017/18. The Board views the current financial year very positively.

[hastings] 26/7/2017 09:23

Agreed rhomboid and good to see that net cash was £300k higher than the broker forecast driven by stronger than expected free cash flow.On EPS worth remembering the effect of dilution and I'm looking at the 2019 forecast 2.1p backed up by an much increased net cash position.Of course another shrewd acquisition would change that somewhat.

[gnnmartin] 26/7/2017 09:01

I was a bit disappointed to see earnings per share unchanged. I haven't done more than skim the results. I guess that was the item that brought in the sellers. Anyhow, price seems to be recovering now.

[pj 1] 26/7/2017 08:55

If you isolate and ignore the ''noise'', this is in a lovely 12m+ uptrend,

[rivaldo] 26/7/2017 08:27

Total volumes are about £30k so far today. Hardly "significant"! Come on Pug, deploy your usual bear shtick somewhere else. A few small sells and a bit of profit-taking in a very illiquid stock doesn't imply anything other than what it is - a pause for breath which will hopefully bring in other buyers.

[pj 1] 26/7/2017 08:24

Lets hope its the IC lemmings bailing out.

[panic investor] 26/7/2017 08:24

Don't currently hold but astounded by the price action here after those results

[pugugly] 26/7/2017 08:20

Some do not like - Marked down and significant sells over buys.

[buywell3] 26/7/2017 08:14

Which means Finncap have gone back to their 2016 share price guidance , it was 30p then

'Behind the curve' ..... 'conservative' ..... but at least better than their previous 20p as I have pointed out.

Perhaps in 2018 afetr a full year of Astles earnings , and what looks like a very decent push coming from all divisions apart from perhaps one where Ken Ford's comment was very short
'Opus, the camera for the art market, generated good steady sales.'

Maybe SDI could sell Opus and use the cash towards the next Sentek or Astles

They seem to be getting better at spotting good fit acquisitions

So rather spending money on Opus ... I think they could get better value now elsewhere

But heh ... what do I know

Just a minor point in an otherwise acceptable set of results


Perhaps after the next acquisition maybe ... Finncap will get up to speed and go for 40p

[rivaldo] 26/7/2017 07:56

Cheers hastings - good to see Finncap moving upwards to 30p.

[zipstuck] 26/7/2017 07:48

Up with events

[hastings] 26/7/2017 07:47

Very happy and much already said but Sentek outperforming and decent cash flow standouts.ProReveal an added extra as outlined in today's FinnCap note which ups target price to 30p but potential for upside on that.Another acquisition in the coming months in the mould of the latest two would also be welcome.

[rivaldo] 26/7/2017 07:30

Good results this morning, plus in particular:

(1) A very bullish outlook:

"The Board is confident that SDI is now in an excellent position for profitable growth through increased revenue and the potential for additional acquisitions in 2017/18. The Board views the current financial year very positively"

(2) Proreveal seems to be making very good progress, being "trialled by NHS hospitals across the UK and the sale in 2017 of eight systems".

I calculate 1.74p adjusted EPS based on £1.3m PBT, a £75k tax charge and 70.97m shares in issue, which is bang on expectations.

I wonder if forecasts for this year of 1.9p EPS will now be increased, as they were left unchanged following the Astles acquisition by Finncap.

[buywell3] 26/7/2017 07:29

ProReveal sales have taken off in the UK NHS

Margins have improved

Profits are up across all divisions

Forward guidance for 2018 looks rosy on all fronts

Astles only added from Jan 2017 when it was bought ie a few months
Astles will add considerably to earnings in 2018 with a full year contribution

It is all looking good , but I was hoping for a bit better
Does that make me a greedy b@stard

I wonder what Finncap will have to say now

[garbetklb] 25/7/2017 22:31

Hi Hastings
If you're going to catch up with Mike Creedon, I'd love you to talk to him about discounted placings - which disadvantage the private investor. It's something that I'll talk to him about myself in due course.....
If you PM me, I'll let you have details of our holdings.
Cheers
Andy

[rhomboid] 25/7/2017 21:20

I invested here for the potential in ProReveal, I'll be very disappointed if there isn't a positive picture of progress, I don't mind a slow start given the customer profile but I do think it should show a degree of acceleration by now...fingers crossed 🤞

[hastings] 25/7/2017 21:09

So, results tomorrow morning and hopefully all is on track as per the earlier update implied.

Particularly interested in the hoped for progress from both Sentek and more latterly Astles and dare we look for something on ProReveal, although I won't be holding my breath on that!
The forward picture re-current prospects and further acquisitions will also be of importance.
Will hopefully catch up with management and pen something later in the day.

[buywell3] 20/7/2017 17:31

IMO there is room for a 20%short term uplift likely for SDI with more to follow

This is based upon forecasts for 2017 and 2018 plus factoring in what IMO is a very good acquisition in Astles where X selling opportunities should arise in the coming 12 months and going forwards.

The results coming next week will only contain around 6 months of Astles

Then we get a full 12 months to follow

I think 20% looks about right without any new acquisition

This data supports that view I feel




My call for now is thus 30p, with a possible retest of 34p if the next trading update is good

18 months from here with another similar acquisition to Astles my call is 40p

GLA

dyor

[buywell3] 20/7/2017 16:11

Judge (JDG) Note the profit 0.4m on a turnover of 57.3M with a EPS of 1.3p and a P/E of 1,426.p giving a Market Cap of 113.24M

Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
... 57.3 .......0.4.... 1.3 .....1,426.9 .... .113.24


This IMO means that SDI has some margin to go higher, I hope Finncap agree


Hoping for around £1.9M profit and 1.7p earnings per share , P/E of 15

Guidance for 2p a share for 2018 ir forward P/E of 13

For a growth stock with a good recent jump of increasing profits = undemanding

Should be P/E of 20



dyor

[rivaldo] 20/7/2017 10:54

A good trading update from JDG this morning hopefully bodes well for SDI too.

[buywell3] 17/7/2017 08:22

buywell says he likes what he sees at Scientific Digital Imaging, he likes charts and TA , those of SDI are both looking promising.


The spread narrowed on friday from 3p , which it has been for a couple of weeks now , to 1p.

A sign that interest is growing as results date looms large



I might moan a bit ... but I like what I see here thus far , the BOD have made shrewd acquisitions to date , and Astles has the makings of being their best yet.

Margins are decent and are rising , not much debt and earnings per share on the rise despite raising cash a couple of times for the acquisitions.

The cherry on the cake , thus far uneaten , is their ProReveal offering to detect protein left from ineffective cleaning of surgical instruments

Not the sort of protein you might want to eat .... nasty stuff .... left over from the previous patient on the surgical instrument used for their operation .... yuck

This stuff can spread things like CJD

and other various nasties.

Whilst the NHS have made noises about implementing an instrument like ProReveal , they move with the speed of a tortoise with a double hernia.
Perhaps 2018 is the year they will implement as some USA hospitals have and use ProReveal as a 'check' on their surgical instrument cleaning processes.

Linda Schultz, Central Services Manager, Piedmont Atlanta Hospital, USA


“We have for many years been testing how well our washing process works by simply looking to see if the surgical instruments are clean. This is not an accurate way of testing and varies depending on who is looking at the instrument. We knew we had to change so in 2016 we purchased the ProReveal.”

“We were amazed at what we could see with the ProReveal and using the test as a benchmarking tool we have managed to get our decontamination process to routinely clean to between 0 and 5 micrograms of residual protein per instrument. ProReveal gives us a level of comfort that the surgical instruments we’re sending back into the operating room are really clean, which makes us proud of the job we’re doing here.”



Testimonials on the product ... (need updating from 2015)


I note that ProReveal has been updated a couple of times to give additional data or data in a different way/format
Perhaps this 2013 clip needs an update as a result


I wonder if it is time to find more/bigger Distributors that are NHS connected ?

ProReveal has the potential to make a lot of money for SDI

It needs to be placed in GOOD sales hands to shift it.

I assume SDI are happy with their USA Distributor

At least a few have been sold there

Re the EU,UK and ROW .... I think work is needed



Put the country in to see the Distributor

We seem to have one small Distributor in the UK, who does not seem to be selling any
appointed 2012 ... time for a change perhaps based upon lack of sales
One in the USA that covers Canada and all the USA
One in China
One in Germany

And that is all I can see ....... moan


Look at this NOTHING since 2015 .... I ask you ..... PLEASE DO SOMETHING


And PLEASE get rid of the name of the old CEO Paul Ellwood from the website and put in Brian Stammers

It looks VERY BAD

As always dyor

[buywell3] 14/7/2017 18:45

The spread narrowed today from 3p , which it has been for a couple of weeks now , to 1p this afternoon.


SCIENTIFIC D. ORD 1P (LSE:SDI) Share Price
25.000
Today's low: 24.110
26.000
Today's high: 26.025

Last trade:25.500
Change: +1.500 (6.25%)
Volume:194,640


Latest trades

Time Price Volume Value
16:27:31 25.5 63,576 16,212
16:14:11 25.98 3,000 779
15:58:21 25.5 12,500 3,188
15:25:54 25.98 4,811 1,250
15:22:06 25.555 30,000 7,667
15:14:33 25.555 16,181 4,135
15:01:51 26.0269 10,000 2,603
14:41:04 24.55 7,500 1,841
13:58:51 24.55 33,021 8,107
13:57:37 24.55 4,040 992
12:19:52 24.11 10,011 2,414

[rivaldo] 14/7/2017 14:54

Looks like the long-term uptrend is continuing into the results - which to repeat will be on the 26th July :o))